Tumors Induce Systemic Immunosuppression through Osteoprogenitor–GMP Cross-talk

Article navigation

Research Watch| July 07 2023

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2023

American Association for Cancer Research

Cancer Discov (2023) 13 (7): 1510.

Abstract

Tumors induce systemic immunosuppression that outlasts tumor burden via osteoprogenitor (OP)–GMP cross-talk.

2023

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.